कृपया अन्य खोज का प्रयास करें
Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Steven V. Edelman | 67 | 2016 | Independent Non-Management Director |
Edward J. Fiorentino | 64 | 2015 | Independent Non-Management Director |
Douglas A. Roeder | 52 | 2015 | Independent Non-Management Director |
Douglas S. Prince | 69 | 2015 | Independent Non-Management Director |
Timothy T. Goodnow | 61 | 2015 | President, CEO & Director |
Stephen P. DeFalco | 61 | 2015 | Independent Chairman |
Anthony R. Raab | 43 | 2020 | Independent Non-Management Director |
Koichiro Sato | 51 | 2023 | Director |
Brian B. Hansen | 56 | 2024 | Director |
Sharon D. Larkin | 60 | 2021 | Independent Non-Management Director |
Francine Ratner Kaufman | 73 | 2019 | Chief Medical Officer & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है